Association between coffee and caffeine intake and risk of COPD: Findings based on NHANES 2007–2012

• Published in: Heart & lung 2024-09, Vol.67, p.53-61
• Main Authors: Liao, Wan-Zhe, Li, Jia-Xin, Feng, Wei-Yi, Xiao, Jia-Qi, Wang, Zi-Xun, Xie, Shuo-Jia, Hu, Yi-Ming, Mao, Jun-Hao, Huang, Ze-Min, Guo, Xu-Guang, Guan, Wei-Jie
• Format: Article
• Language: English
• Subjects: Caffeine; Coffee; COPD; Cross-sectional study; NHANES
• ISSN: 0147-9563; 1527-3288; 1527-3288
• DOI: 10.1016/j.hrtlng.2024.04.015

•The research analyzes how coffee and caffeine intake are specifically related to the risk of COPD and overall lung function.•Smooth-fitting curves provide important insights into the dose-effect relationship between the exposures and the endpoints.•Potential cutting points have been identified, which can serve as personalized references for safe coffee or caffeine intake in COPD patients. The association between coffee and caffeine intake and the risk of COPD and lung function has not been thoroughly discussed in Americans, with subgroup and threshold effects remaining unclear. This study investigated the association between coffee and caffeine consumption and the risk of chronic obstructive pulmonary disease (COPD) as well as lung function utilizing data from the NHANES 2007–2012. We assessed the associations of coffee and caffeine consumption with the risk of COPD and lung function parameters, including FEV1 and FVC, adjusting for common demographic and disease characteristics in a cross-sectional analysis of NHANES data. A total of 9763 participants were included in the study, and 592 were diagnosed with COPD. Multivariate regression models revealed positive associations between coffee and caffeine consumption and the risk of COPD and lung function. Subgroup analyses stratified by sex, DM, hypertension status, and smoking habits identified potential effect modifiers as well as inflection points from threshold effect examinations. The results of this cross-sectional study indicated significant positive correlations between coffee and caffeine consumption and the risk of COPD. Additionally, positive correlations between exposure variables and FEV1 and FVC were detected. Among the stratification factors, smoking status exhibited the most potential for modifying effects. Future practices and research are needed to validate the results and explore the underlying mechanisms